Back
Climb Bio, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
CLYM
Climb Bio, Inc.
Last Price:
$5.66
Seasonality Move:
38.16%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CLYM is experiencing slight buying pressure.
Climb Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.54 | Sell |
| 20-day SMA: | 5.12 | Buy |
| 50-day SMA: | 4.27 | Buy |
| 200-day SMA: | 2.34 | Buy |
| 8-day EMA: | 5.3 | Buy |
| 20-day EMA: | 4.03 | Buy |
| 50-day EMA: | 2.26 | Buy |
| 200-day EMA: | 0.68 | Buy |
Climb Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 57.93 | Buy |
| Chaikin Money Flow: | 45369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.35 - 5.47) | Buy |
| Bollinger Bands (100): | (1.69 - 4.51) | Buy |
Climb Bio, Inc. Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Climb Bio, Inc. Stock
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 5.50 while CLYM 8-day simple moving average is 5.54, which is a Sell signal.
-
The stock price of CLYM is 5.50 while Climb Bio, Inc. 20-day SMA is 5.12, which makes it a Buy.
-
Climb Bio, Inc. 50-day simple moving average is 4.27 while CLYM share price is 5.50, making it a Buy technically.
-
CLYM stock price is 5.50 and Climb Bio, Inc. 200-day simple moving average is 2.34, creating a Buy signal.
CLYM Technical Analysis vs Fundamental Analysis
Buy
73
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. a Buy or a Sell?
-
Climb Bio, Inc. stock is rated a BuyThe current Climb Bio, Inc. [CLYM] share price is $5.50. The Score for CLYM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Climb Bio, Inc. Stock Info
Market Cap:
375M
Price in USD:
5.50
Share Volume:
347.8K
Climb Bio, Inc. 52-Week Range
52-Week High:
6.22
52-Week Low:
1.05
Buy
73
Climb Bio, Inc. (CLYM)
is a Buy
Climb Bio, Inc. Share Price Forecast
-
What is the Climb Bio, Inc. stock price today?The Climb Bio, Inc. stock price is 5.50 USD today.
-
Will CLYM stock go up or go down?Climb Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Climb Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Climb Bio, Inc. is not overvalued.
Is Climb Bio, Inc. Stock a Buy?
-
Climb Bio, Inc. share price is 5.50 while CLYM 8-day exponential moving average is 5.30, which is a Buy signal.
-
The stock price of CLYM is 5.50 while Climb Bio, Inc. 20-day EMA is 4.03, which makes it a Buy.
-
Climb Bio, Inc. 50-day exponential moving average is 2.26 while CLYM share price is 5.50, making it a Buy technically.
-
CLYM stock price is 5.50 and Climb Bio, Inc. 200-day simple moving average is 0.68, creating a Buy signal.
Fundamental Analysis of Climb Bio, Inc.
Is Climb Bio, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Climb Bio, Inc.
Should I short Climb Bio, Inc. stock?
-
CLYM Moving Average Covergence Divergence (MACD) indicator is 1.38, suggesting Climb Bio, Inc. is a Buy
-
Climb Bio, Inc. Relative Strength Index (RSI) is 57.93, which suggest Climb Bio, Inc. is overbought
-
The Bollinger Bands (25) for Climb Bio, Inc. is (4.35 - 5.47), which suggest Climb Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Climb Bio, Inc. is (1.69 - 4.51), which suggest Climb Bio, Inc. is a Buy
* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.